T.J. Eberlein
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Co-authors
- Peter S. Goedegebuure (1 shared paper)Ichiro Yoshino (1 shared paper)George E. Peoples (1 shared paper)Robert W. Smith (1 shared paper)David C. Linehan (1 shared paper)Deric D. Schoof (3 shared papers)Barbara Silver (2 shared papers)S J Schnitt (2 shared papers)
- Journals
- The Journal of Immunology (2 papers)Journal of Clinical Oncology (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)American Journal of Roentgenology (1 paper)Surgical Oncology (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
T.J. Eberlein
53 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 76
- Cancer Research 380
- Immunology 461
- Oncology 581
- Pathology and Forensic Medicine 317
- Hepatology 122
Countries citing papers authored by T.J. Eberlein
This map shows the geographic impact of T.J. Eberlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.J. Eberlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.J. Eberlein more than expected).
Fields of papers citing papers by T.J. Eberlein
This network shows the impact of papers produced by T.J. Eberlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.J. Eberlein. The network helps show where T.J. Eberlein may publish in the future.
Co-authors
The 25 scholars most cited alongside T.J. Eberlein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 372 | |
| 2 | 2006 | 200 | |
| 3 | 1993 | 164 | |
| 4 | 2008 | 109 | |
| 5 | Adoptive immunotherapy of human cancer using low-dose recombinant interleukin 2 and lymphokine-activated killer cells. | 1988 | 73 |
| 6 | 1989 | 50 | |
| 7 | 2010 | 30 | |
| 8 | 1981 | 24 | |
| 9 | 1988 | 22 | |
| 10 | 2011 | 19 | |
| 11 | 2009 | 15 | |
| 12 | Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanoma. | 1997 | 14 |
| 13 | 2011 | 13 | |
| 14 | 2008 | 13 | |
| 15 | Pancreatic cancer associated ascites-derived CTL recognize a nine-amino-acid peptide GP2 derived from HER2/neu. | 1999 | 11 |
| 16 | 1992 | 10 | |
| 17 | 1992 | 8 | |
| 18 | 2012 | 8 | |
| 19 | 2007 | 8 | |
| 20 | 1995 | 8 |
About T.J. Eberlein
T.J. Eberlein is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Hepatology, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Gastric Cancer Management and Outcomes (10 papers), Pancreatic and Hepatic Oncology Research (8 papers), Immunotherapy and Immune Responses (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Colorectal Cancer Surgical Treatments (5 papers). The work is most often cited by research in Cancer Research (380 citations), Immunology (461 citations), Oncology (581 citations), Pathology and Forensic Medicine (317 citations) and Hepatology (122 citations). T.J. Eberlein has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Peter S. Goedegebuure, Ichiro Yoshino, George E. Peoples, Robert W. Smith, David C. Linehan, Deric D. Schoof, Barbara Silver, S J Schnitt, L. Shulman and James L. Connolly. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, American Journal of Roentgenology and Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.